Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy
Objective: We describe linezolid tissue penetration in two diabetic patients with lower-extremity ulcers, measured by in vivo microdialysis, before and after hyperbaric oxygen (HBO 2 ) therapy. Methods: Each diabetic patient received a single orally administered dose of linezolid 600mg within one we...
Saved in:
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/12766 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.12766 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.127662018-05-03T15:39:05Z Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy Pornpan Koomanachai Rebecca A. Keel Kelly K. Johnson-Arbor Larry A. Suecof David P. Nicolau Joseph L. Kuti Hartford Hospital Mahidol University University of Connecticut Connecticut Surgical Group Medicine Objective: We describe linezolid tissue penetration in two diabetic patients with lower-extremity ulcers, measured by in vivo microdialysis, before and after hyperbaric oxygen (HBO 2 ) therapy. Methods: Each diabetic patient received a single orally administered dose of linezolid 600mg within one week of initiating an eight-week HBO 2 course for treatment of his or her Wagner Grade 3 lowerextremity wound. A microdialysis catheter was placed at the margin of the wound for collection of extracellular tissue fluid. Blood and tissue samples were collected hourly over the following 12 hours. After completion of HBO 2, each patient received a second dose of linezolid 600mg, the microdialysis catheter was reinserted in same location, and blood/tissue samples were recollected for comparison. Results: Patient 1 completed all eight weeks of HBO 2, while Patient 2 completed only five of eight weeks. Based on the 12-hour area under the curve ratio between extracellular tissue fluid and blood, linezolid penetration was 0.474 and 0.479 for Patients 1 and 2, respectively, at the beginning of HBO 2. After completing HBO 2, penetration improved in both patients to 0.950 and 0.757, respectively. Conclusion: Tissue concentrations of linezolid at the site of lower extremity ulcers improved following a course of HBO 2 in two patients with diabetes. © 2011 Undersea & Hyperbaric Medical Society, Inc. 2018-05-03T08:39:05Z 2018-05-03T08:39:05Z 2011-01-01 Article Undersea and Hyperbaric Medicine. Vol.38, No.1 (2011), 11-16 10662936 2-s2.0-79953047375 https://repository.li.mahidol.ac.th/handle/123456789/12766 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953047375&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Pornpan Koomanachai Rebecca A. Keel Kelly K. Johnson-Arbor Larry A. Suecof David P. Nicolau Joseph L. Kuti Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
description |
Objective: We describe linezolid tissue penetration in two diabetic patients with lower-extremity ulcers, measured by in vivo microdialysis, before and after hyperbaric oxygen (HBO 2 ) therapy. Methods: Each diabetic patient received a single orally administered dose of linezolid 600mg within one week of initiating an eight-week HBO 2 course for treatment of his or her Wagner Grade 3 lowerextremity wound. A microdialysis catheter was placed at the margin of the wound for collection of extracellular tissue fluid. Blood and tissue samples were collected hourly over the following 12 hours. After completion of HBO 2, each patient received a second dose of linezolid 600mg, the microdialysis catheter was reinserted in same location, and blood/tissue samples were recollected for comparison. Results: Patient 1 completed all eight weeks of HBO 2, while Patient 2 completed only five of eight weeks. Based on the 12-hour area under the curve ratio between extracellular tissue fluid and blood, linezolid penetration was 0.474 and 0.479 for Patients 1 and 2, respectively, at the beginning of HBO 2. After completing HBO 2, penetration improved in both patients to 0.950 and 0.757, respectively. Conclusion: Tissue concentrations of linezolid at the site of lower extremity ulcers improved following a course of HBO 2 in two patients with diabetes. © 2011 Undersea & Hyperbaric Medical Society, Inc. |
author2 |
Hartford Hospital |
author_facet |
Hartford Hospital Pornpan Koomanachai Rebecca A. Keel Kelly K. Johnson-Arbor Larry A. Suecof David P. Nicolau Joseph L. Kuti |
format |
Article |
author |
Pornpan Koomanachai Rebecca A. Keel Kelly K. Johnson-Arbor Larry A. Suecof David P. Nicolau Joseph L. Kuti |
author_sort |
Pornpan Koomanachai |
title |
Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
title_short |
Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
title_full |
Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
title_fullStr |
Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
title_full_unstemmed |
Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
title_sort |
linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/12766 |
_version_ |
1763496338781110272 |